Valeant Tries To Zap Claims In 4 Securities Fraud Suits
Valeant Pharmaceuticals International Inc. on Friday asked a New Jersey federal court to pare four securities fraud suits brought against it by institutional investors, arguing that some of the investors' claims...To view the full article, register now.
Already a subscriber? Click here to view full article